Professional Documents
Culture Documents
Ws Ahf - Intro Apicd 2017 - Edited
Ws Ahf - Intro Apicd 2017 - Edited
ST SEGMENT ELEVATION
MYOCARDIAL INFARCTION
Kurnia Mebrillianttari
PREVALENCE
Worldwide, ischaemic heart disease is the single most common cause of death and its
frequency is increasing
Atypical:
shortness of breath
nausea/vomiting
fatigue
palpitations
or syncope
STEMI Diagnosis
Signs
12 Lead ECG
coronary artery
occlusion/global
ischaemia
in the absence of
characteristic ST
elevation
Reperfusion strategy time in patients presenting
Oxygen
Intubated if indicated
Primary PCI
DAPT
Aspirin loading dose 150-300 mg chewing, maintenance 75-100 mg
+
Ticagrelor loading dose 180 mg, maintenace 2x 90 mg
/ Prasugrel 60 mg, maintenance 1x10mg
/ Clopidogrel 600 mg, maintenance 1x75 mg
IV Anticoagulant
UFH 70-100 IU/kg iv bolus without GP IIb/IIIa inhibitor or 50-70 IU/kg iv with
GP IIb/IIIa
DAPT
Aspirin loading dose 150-300 mg chewing, maintenance 75-100 mg
+
Clopidogrel 300 mg, maintenance 1x75 mg
IV Anticoagulant
UFH 60 IU/kg iv bolus (max 4000IU) maintenance 12IU/kg/hr 24-48 hr
/ Enoxaparin
Age < 75 30mg iv bolus, next 15 minute 1 mg/kg sc every 12 hour
Age >75 no iv bolus, start 0.75 mg/kg sc
eGFR <30mL/min/1.73 m2 every 24 hour
CCU/ICCU
Provide all aspects of care for STEMI patients,
Treatment of ischaemia, severe heart failure, arrhythmias, and common
comorbidities.
Monitoring
All STEMI patients have ECG monitoring for a minimum of 24 h
Length of stay
A minimum of 24 h in CCU/ICCU whenever possible, after which they may be
moved to a step-down monitored bed for an additional 24–48 h.
Long Term Therapies for STEMI
Antithrombotic therapy
DAPT, combining aspirin and a P2Y inhibitor (prasugrel, ticagrelor, or
1
Beta-blockers
Nitrates
Routine use of nitrates in STEMI was of no benefit
Intravenous nitrates may be useful during the acute phase in patients
with hypertension or heart failure
Calcium antagonists